ArticleOncology reports2021

BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP‑1 cells via the Rb/E2F1 pathway in cervical carcinoma.

Limin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.